Mr Hiroshi Kobayashi > Abe, Ikubo & Katayama > Tokyo, Japan > Lawyer Profile

Abe, Ikubo & Katayama
GranTokyo South Tower,
1-9-2 Marunouchi, Chiyoda-ku,
Tokyo 100-6613,
Japan
Hiroshi Kobayashi photo

Work Department

Intellectual Property Department

Position

Partner

Career

・Itoh & Company (Patent Firm) (1983)

・Registered as patent attorney (1985)

・Joined Dow Chemical Japan (1988-1990: Worked at Dow Corporate Patent Dept. in U.S.A.) (1987)

・Promoted to General Manager, Patent Dept., Dow Chemical Japan (1989)

・Joined Pfizer Japan as International Patent Manager, Patent Dept.  (1993)

・Promoted to General Manager, IP Dept., Pfizer Japan (1995)

・Joined Abe, Ikubo & Katayama (2001)

・Qualified as patent attorney admitted to practice intellectual property infringement litigation (2005)

・Visiting Professor at Renmin University of China (2010-2011)

Languages

Japanese and English

Memberships

・Japan Patent Attorneys Association (JPAA)

・International Activity Center of JPAA

・AIPPI

・IP Committee of Japan Science and Technology Agency

・Institution of Professional Engineers (Biotechnology), Japan (ex-member of PIPA,JIPA and JPMA)

Education

・Graduated from Sophia University with BS in Applied Chemistry (1983)

・LLB, Chuo University (2003)

・LLM, George Mason University School of Law (2022)

Lawyer Rankings

Japan > Intellectual property: Independent local firms

(Leading partners: Benrishi)

Hiroshi KobayashiAbe, Ikubo & Katayama

The team at Abe, Ikubo & Katayama has ‘deep knowledge and expertise’ in IP infringement litigation and procurement, benefiting from a combination of experienced litigators and patent lawyers in the chemical, biotech, software, and electronics fields. The team is jointly led by Eiji Katayama, who is well-versed in domestic and cross-border intellectual property-related matters, and Hiroshi Kobayashi, who is experienced in infringement, opinion, licensing, and opposition patent-related matters. Junichi Kitahara and Makoto Hattori focus on patent litigation and trade secret litigations, respectively, representing both domestic and international clients. Mami Hino is a name to note in relation to pharma patent protection.